Fecha de publicación: 30/09/2022 Fuente: WIPO "hemp" The invention relates to compositions and methods containing hemp and/or cannabis- derived cannabidiol (CBD) for topical use in treating female sexual dysfunction induced by antidepressants, including, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin/norepinephrine reuptake inhibitors (SNRIs), and other anti-depressants.